University of Catania
🇮🇹Italy
- Country
- 🇮🇹Italy
- Ownership
- Private
- Established
- 1434-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.unict.it/en
Real-World Study Shows Pepaxti Effective in Heavily Pretreated Multiple Myeloma Patients
Italian researchers report promising results for Pepaxti (melflufen) in treating triple-class refractory multiple myeloma patients, achieving a 37.5% overall response rate despite patients having received a median of 3.5 prior therapies.